RabMAb

Anti-Chk1 (phospho S296)抗体[EPR915] (ab79758)

发表研究结果有使用 ab79758?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab79758 被引用在 6 文献中.

  • Bryant C  et al. Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells. Mol Cancer 13:147 (2014). WB . PubMed: 24913641
  • Rawlinson R & Massey AJ ?H2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments. BMC Cancer 14:483 (2014). WB ; Human . PubMed: 24996846
  • Bryant C  et al. Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers. BMC Cancer 14:570 (2014). WB . PubMed: 25104095
  • Huh J & Piwnica-Worms H CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 33:213-26 (2013). PubMed: 23109433
  • Ma CX  et al. A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer. Breast Cancer Res Treat 137:483-92 (2013). ICC/IF ; Human . PubMed: 23242585
  • Ma CX  et al. Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. J Clin Invest 122:1541-52 (2012). WB . PubMed: 22446188

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"